Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2025-12-25 @ 2:31 AM
NCT ID:
NCT00504634
Eligibility Criteria:
Inclusion Criteria:
* Patients with multiple myeloma at least 3 months post allogeneic transplant who either failed to achieve a complete remission or are relapsing.
* Allograft performed from a related donor who is HLA-compatible (5/6 or 6/6), or class I serologic match and class II molecular matched unrelated donor).
* Zubrod Points Scale (PS) \< 2, life expectancy is not severely limited by concomitant illness.
* Patient willing and able to sign informed consent.
* Patients less than 70 years of age.
Exclusion Criteria:
* Active Central Nervous System (CNS) disease.
* Uncontrolled acute or chronic Graft-versus-host disease (GVHD).
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
70 Years
Study:
NCT00504634
Study Brief:
Protocol Section:
NCT00504634